Ginkgo Bioworks Holdings Inc.(DNA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

DNA Ginkgo Bioworks Holdings Inc.

Market Closed 05-15 16:00:00 EDT

7.71

-0.14

-1.78%

盘后7.78

+0.07+0.91%

19:58 EDT

High7.82	Low7.53	Vol1.05M
Open7.58	D1 Closing7.85	Amplitude3.69%
Mkt Cap503.65M	Tradable Cap372.07M	Total Shares65.32M
T/O8.02M	T/O Rate2.17%	Tradable Shares48.26M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"DNA","market":"US","secType":"STK","nameCN":"Ginkgo Bioworks Holdings Inc.","latestPrice":7.71,"timestamp":1778875200000,"preClose":7.85,"halted":0,"volume":1045745,"hourTrading":{"tag":"盘后","latestPrice":7.78,"preClose":7.71,"latestTime":"19:58 EDT","volume":20593,"amount":159928.7825,"timestamp":1778889501732,"change":0.07,"changeRate":0.009079,"amplitude":0.028534},"delay":0,"changeRate":-0.01783439490445856,"floatShares":48258700,"shares":65324491,"eps":-5.360151,"marketStatus":"Market Closed","change":-0.14,"latestTime":"05-15 16:00:00 EDT","open":7.58,"high":7.82,"low":7.53,"amount":8021312.774605,"amplitude":0.036943,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.360151,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1779091200000},"marketStatusCode":7,"adr":0,"exchange":"NYSE","adjPreClose":7.85,"preHourTrading":{"tag":"盘前","latestPrice":7.6815,"preClose":7.85,"latestTime":"09:27 EDT","volume":4244,"amount":32928.4303824,"timestamp":1778851667328,"change":-0.1685,"changeRate":-0.021465,"amplitude":0.046943},"postHourTrading":{"tag":"盘后","latestPrice":7.78,"preClose":7.71,"latestTime":"19:58 EDT","volume":20593,"amount":159928.7825,"timestamp":1778889501732,"change":0.07,"changeRate":0.009079,"amplitude":0.028534},"volumeRatio":0.7024314334896185,"impliedVol":0.7026,"impliedVolPercentile":0.0239},"requestUrl":"/m/hq/s/DNA/wiki","defaultTab":"wiki","newsList":[{"id":"2635056558","title":"DNA X, Inc. Delays Quarterly Filing After Asset Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2635056558","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635056558?lang=en_us&edition=fundamental","pubTime":"2026-05-16 07:31","pubTimestamp":1778887871,"startTime":"0","endTime":"0","summary":"Sonim Technologies ( ($SONM) ) has released a notification of late filing. DNA X, Inc., formerly Sonim Technologies Inc., has filed a Form 12b-25 t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/dna-x-inc-delays-quarterly-filing-after-asset-sale?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/dna-x-inc-delays-quarterly-filing-after-asset-sale?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","BK4109","SOCL","SONM","DNA","BK4139","BK4170"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635741983","title":"Datar Cancer Genetics Receives Landmark US FDA Clearance for CellDx-Tissue, a Comprehensive Genomic Profiling Assay for Solid Tumors Using DNA + RNA","url":"https://stock-news.laohu8.com/highlight/detail?id=2635741983","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635741983?lang=en_us&edition=fundamental","pubTime":"2026-05-14 23:58","pubTimestamp":1778774280,"startTime":"0","endTime":"0","summary":"Clearance Recognises CellDx-Tissue's Dual-Analyte DNA and RNA Workflow Across 517 Cancer-Associated Genes, with ALK, RET and ROS1 Fusion Calls on RNA-Level EvidenceNASHIK, India, May 14, 2026 /PRNewswire/ -- Datar Cancer Genetics , a global precision oncology company, today announced that its tissue-based comprehensive genomic profiling  assay for all solid tumors, CellDx-Tissue, has been cleared by the US Food and Drug Administration .The clearance strengthens DCG's position in delivering a breakthrough platform intended for use by oncologists globally to make personalised clinical management decisions in accordance with professional guidelines and complements the company's earlier US FDA Breakthrough Device Designations for its liquid biopsy platforms.","market":"sg","thumbnail":"https://mma.prnewswire.com/media/2980273/Datar_Cancer_Genetics_US_FDA.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2980273/Datar_Cancer_Genetics_US_FDA.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/datar-cancer-genetics-receives-landmark-us-fda-clearance-for-celldx-tissue-a-comprehensive-genomic-profiling-assay-for-solid-tumors-using-dna--rna-302772619.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4211","BK4585","BK7111","NGS","LABU","BK7055","BK4179","BK4121","BK4588","DNA","IE0009354923.USD","BK4109","DCG.AU","RNA","LARK","NGS.AU","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634256068","title":"Lotus Unveils Focus 2030 – Reinforcing Brand DNA with an All-New Hybrid-V8 Supercar","url":"https://stock-news.laohu8.com/highlight/detail?id=2634256068","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634256068?lang=en_us&edition=fundamental","pubTime":"2026-05-12 07:00","pubTimestamp":1778540400,"startTime":"0","endTime":"0","summary":"Focus 2030 targets market competitiveness and sustainable business operations through brand reinforcement and unification, close partner collaboration, financial discipline, and multi-powertrain strat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/11/3292430/0/en/Lotus-Unveils-Focus-2030-Reinforcing-Brand-DNA-with-an-All-New-Hybrid-V8-Supercar.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4109","BK4119","BK4121","BK4588","NEV","GT","BK4585","BK4139","DNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634723532","title":"Analysts Conflicted on These Healthcare Names: Ginkgo Bioworks Holdings (DNA), Xencor (XNCR) and Alto Neuroscience, Inc. (ANRO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2634723532","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634723532?lang=en_us&edition=fundamental","pubTime":"2026-05-11 23:50","pubTimestamp":1778514615,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Ginkgo Bioworks Holdings (DNA), Xencor (XNCR) and Alto Neuroscien...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-ginkgo-bioworks-holdings-dna-xencor-xncr-and-alto-neuroscience-inc-anro-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-ginkgo-bioworks-holdings-dna-xencor-xncr-and-alto-neuroscience-inc-anro-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","XLV","BK4139","DNA","ANRO","BK4109","LU0128526141.USD","XBI","BK4588","BK4121","BK4137","BK4007","LABU","BK4581","HCSG","XNCR","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634422374","title":"Is Inovio (INO) Turning Fresh DNA Medicine Data Into a More Coherent Investment Story?","url":"https://stock-news.laohu8.com/highlight/detail?id=2634422374","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634422374?lang=en_us&edition=fundamental","pubTime":"2026-05-10 18:35","pubTimestamp":1778409314,"startTime":"0","endTime":"0","summary":"Inovio Pharmaceuticals recently announced plans to release its Q1 2026 earnings after market close on May 13, 2026, alongside a conference call and upcoming scientific presentations on its DNA medicine pipeline for HPV-related diseases, cancer, and infectious diseases.\nInvestor attention has intensified as Inovio’s DNA vaccine and gene transfer programs gain visibility, supported by significant institutional ownership and new clinical data disclosures on candidates such as INO-3107 and its...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ino/inovio-pharmaceuticals/news/is-inovio-ino-turning-fresh-dna-medicine-data-into-a-more-co","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ino/inovio-pharmaceuticals/news/is-inovio-ino-turning-fresh-dna-medicine-data-into-a-more-co","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["INO","BK4121","BK4583","BK4139","BK4109","DNA","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633517753","title":"Ginkgo Bioworks Q1 revenue falls 49% on restructuring","url":"https://stock-news.laohu8.com/highlight/detail?id=2633517753","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633517753?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:58","pubTimestamp":1778187507,"startTime":"0","endTime":"0","summary":"Ginkgo Bioworks Q1 revenue falls 49% on restructuringOverviewSynthetic biology platform's Q1 revenue fell 49% yr/yr, driven by program rationalizationQ1 adjusted EBITDA loss narrowed slightly from pri","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nL1N41K1KV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0787776722.HKD","LU0029864427.USD","IE0005OL40V9.USD","LU0265550946.USD","LU0494093205.USD","LU2860962120.EUR","IE00BMPRXR70.SGD","IE00B7KXQ091.USD","LU0011850046.USD","IE00BQXX3D17.EUR","LU1629891620.HKD","LU2764263203.CNY","LU2896262040.SGD","LU0203202063.USD","LU2089284900.SGD","LU2023250330.USD","LU2420271590.USD","BK4220","SG9999018865.SGD","LU0353189763.USD","LU0314104364.USD","LU1064131342.USD","LU1127390331.HKD","IE00B7SZLL34.SGD","LU0345774391.USD","LU2108987350.USD","IE0001KFT4U8.USD","LU1153585028.USD","BK4533","LU2361044865.SGD","IE000WAW04H5.SGD","IE0003U64NQ7.SGD","IE0004086264.USD","LU0174119429.USD","LU0345774631.USD","LU1069344957.HKD","BK4566","LU1935042991.SGD","LU0320765489.SGD","IE0004091025.USD","BK4109","IE00BJLML261.HKD","LU0354030511.USD","LU0138981039.USD","IE00BKPKM429.USD","LU1883839398.USD","LU1066051811.HKD","SG9999004303.SGD","LU0256863902.USD","SG9999002224.SGD","LU1823568750.SGD","LU1935042215.USD","LU0234572021.USD","LU1778281490.HKD","LU1917777945.USD","LU0289941410.SGD","LU2023250843.SGD","BK4543","IE000ITXATA3.USD","LU2023251221.USD","LU0354030438.USD","LU0109391861.USD","LU0256863811.USD","LU1116320737.USD","LU0456855351.SGD","LU2168564065.EUR","LU0345769128.USD","LU1934455863.HKD","SGXZ99366536.SGD","LU0689472784.USD","LU1935043536.SGD","IE00B4YYXB79.USD","LU2213496289.HKD","LU1880398471.USD","IE000YTNTUN2.SGD","BK4596","LU0096362180.USD","LU1084165304.USD","LU1839511570.USD","LU2211815571.USD","LU1935043023.USD","LU0289960550.SGD","IE00BWXC8680.SGD","LU0310800379.SGD","LU2471134523.USD","DNA","LU2250418816.HKD","LU0820561818.USD","LU0965509101.SGD","LU0708994859.HKD","LU1435385759.SGD","LU1267930490.SGD","LU0053666078.USD","LU1720051017.SGD","LU2168564222.USD","IE00BKDWB100.SGD","LU0077335932.USD","LU1201861165.SGD","AMZU","LU1934455194.USD","IE0009G5SDU7.USD","LU2487616109.SGD","LU1074936037.SGD","LU0130103400.USD","LU0642271901.SGD","LU2237957811.SGD","LU0267386448.USD","SG9999002232.USD","AMZP","IE00BJJMRY28.SGD","SG9999014880.SGD","IE00B19Z3B42.SGD","LU0965509283.SGD","LU1496350171.SGD","LU0208291251.USD","LU0308772762.SGD","LU2077746001.SGD","LU2720916845.USD","IE00B3S45H60.SGD","BK4604","BK4588","LU0109392836.USD","LU1868837300.USD","LU2023250504.SGD","LU2168563687.JPY","LU1718418525.SGD","BK4550","SG9999015945.SGD","LU1861558580.USD","LU0210528500.USD","LU1046421795.USD","LU0417517546.SGD","LU1935042488.USD","LU1316542783.SGD","LU2028103732.USD","LU0823434583.USD","BK4503","LU0158827781.USD","IE00B5949003.HKD","LU2552382132.HKD","LU0302445910.USD","LU2242650005.HKD","GB00BDT5M118.USD","LU0130102774.USD","LU2317271919.USD","LU0648001328.SGD","LU2326559502.SGD","LU1791710582.SGD","LU2125154778.USD","LU1280957306.USD","LU2125154935.USD","LU1066051225.USD","LU0786609619.USD","LU0276348264.USD","LU0390134368.USD","IE000KEQY171.SGD","LU2602419157.SGD","LU0175139822.USD","LU2264538146.SGD","LU0985320562.USD","IE00B4JS1V06.HKD","LU0061474705.USD","LU0056508442.USD","SGXZ81514606.USD","IE00B19Z8W00.USD","LU0070217475.USD","LU2065169927.USD","BK4548","BK4535","LU1934455277.USD","LU1035775433.USD","LU0965508806.USD","LU1551013425.SGD","LU0965509010.AUD","IE0002270589.USD","LU0683600562.USD","LU0724617625.USD","LU0157215616.USD","LU2168564495.EUR","LU2111349929.HKD","LU2089283258.USD","LU0210536198.USD","LU0640476718.USD","IE00BMPRXQ63.HKD","LU2275660780.HKD","LU2063271972.USD","IE00B19Z9505.USD","LU0823421416.USD","SG9999014898.SGD","BK4532","LU0316494557.USD","LU1261432733.SGD","LU0251132253.USD","USAW.SI","IE00BZ1G4Q59.USD","LU1674673691.USD","IE00BK4W5L77.USD","AMZY","IE000BZT7R73.USD","LU1674673428.USD","SG9999018857.SGD","LU1868837136.USD","LU0107464264.USD","LU0238689110.USD","LU2362541273.HKD","LU0980610538.SGD","LU0097036916.USD","LU2552382058.USD","LU2430703095.HKD","LU1244550494.USD","LU0154236417.USD","SG9999014906.USD","LU0048584097.USD","IE00BMPRXN33.USD","LU2746668974.SGD","BK4538","LU2462591350.SGD","BK4524","LU0211328371.USD","LU0788109477.HKD","LU1037948897.HKD","LU2168564149.EUR","LU2505996681.GBP","SG9999014914.USD","BK4559","LU0323591593.USD","LU2237957902.USD","IE000SO60NU8.SGD","IE0004445239.USD","LU2083900584.USD","LU0072461881.USD","LU2463028550.USD","LU2087621335.USD","BK4561","LU1066053197.SGD","LU1244550577.SGD","LU0648000940.SGD","LU2750360641.GBP","LU0820561909.HKD","LU0964807845.USD","LU2471134796.USD","LU0823434740.USD","LU0162691827.USD","IE00BJTD4N35.SGD","LU0127658192.USD","SG9999015952.SGD","SGXZ23171101.USD","LU0096364046.USD","LU0215105999.USD","LU1366333091.USD","LU2357305700.SGD","LU2462157665.USD","IE00BFSS7M15.SGD","LU0348723411.USD","IE00B1XK9C88.USD","LU0823411888.USD","IE00BQXX3C00.GBP","LU1633808545.USD","IE0009356076.USD","BK4534","BK4581","LU2087625088.SGD","LU1244550221.USD","LU1868836591.USD","LU0170899867.USD","LU2360106780.USD","IE00BJTD4V19.USD","LU0198837287.USD","LU1145028129.USD","LU2505996509.AUD","LU2054465674.USD","LU0210533765.USD","IE00B1BXHZ80.USD","LU2271345857.HKD","IE0034235303.USD","LU1691799644.USD","LU0070302665.USD","IE000F7OJYX1.SGD","LU2106854487.HKD","LU1366192091.USD","HK0000914686.HKD","BK4122","LU0128525929.USD","LU2360032135.SGD","LU1852331112.SGD","LU0889565833.HKD","LU2471134952.CNY","LU0265550359.USD","LU2236285917.USD","LU0345770993.USD","LU2471134879.HKD","LU0310799852.SGD","LU2065170008.USD","LU2746668461.USD","LU1988902786.USD","LU1804176565.USD","IE00B5TLWC47.USD","LU2237438978.USD","LU1720051108.HKD","BK4585","IE00BYQQ9H92.USD","BK4121","LU1868836757.USD","LU1267930730.SGD","LU0082616367.USD","LU2265009873.SGD","LU1814569148.SGD","SG9999015978.USD","SGXZ31699556.SGD","LU0158827948.USD","LU0823421333.USD","LU1119994496.HKD","LU1880398554.USD","SG9999000418.SGD","LU2242649171.HKD","LU1232071149.USD","LU2417539215.USD","LU2065171402.SGD","IE00BFXG0V08.USD","IE00BJJMRX11.SGD","AMZW","IE000W1ABFV2.USD","IE00BK4W5M84.HKD","IE00B775H168.HKD","LU0345770308.USD","BK4554","LU2430703178.SGD","LU0861579265.USD","LU1989764748.USD","LU0345768740.USD","LU0943347566.SGD","LU1037948541.HKD","HK0000532082.HKD","LU1861127337.USD","LU2456880835.USD","LU1974910355.USD","HK0000304805.HKD","LU0079474960.USD","LU0080751232.USD","LU1551013342.USD","IE00BFSS8Q28.SGD","LU0061474960.USD","BK4592","SG9999015986.USD","LU2211817866.USD","BK4612","LU0061475181.USD","LU2764262908.HKD","SG9999017495.SGD","LU2247934214.USD","LU0320765059.SGD","LU2461242641.AUD","HK0000914660.USD","LU1066051498.USD","LU2452424414.USD","LU0342679015.USD","LU0466842654.USD","LU2592432038.USD","LU1429558221.USD","LU2637965513.SGD","LU1868836914.USD","LU2065171311.SGD","LU1815333072.USD","LU0882574139.USD","IE00B19Z8X17.USD","IE00BKVL7J92.USD","IE00B775SV38.USD","LU0719512351.SGD","LU0708995401.HKD","AZYY","BK4579","SG9999001077.SGD","LU0312595415.SGD","LU0820562030.AUD","BK4598","LU2552382215.SGD","LU1235294995.USD","LU2764263039.SGD","IE0004445015.USD","AMZD","LU2361044949.HKD","LU0203201768.USD","LU2403377893.USD","LU0072462426.USD","LU0345769631.USD","BK4507","IE00B3SWFQ91.USD","LU0149725797.USD","LU2092937148.SGD","LU1323610961.USD","SGXZ51526630.SGD","LU1861559042.SGD","IE00B19Z3581.USD","IE00BQXX3F31.USD","LU1791710400.SGD","LU2543165471.USD","LU2362540622.SGD","LU2756315318.SGD","LU1267930573.SGD","IE00BN29S564.USD","IE0000B7K699.USD","HK0000304797.USD","BK4139","LU2361045086.USD","LU1201861249.SGD","LU1803068979.SGD","LU1116320901.HKD","LU0211327993.USD","LU2750360997.AUD","LU0133085943.USD","LU2362541513.USD","LU0353189680.USD","LU1496350502.SGD","LU2756315664.SGD","LU2430703251.USD","LU0234570918.USD","LU2092627202.USD","LU2097829019.USD","BK4551","LU0528227936.USD","BK4527","LU1989764664.SGD","LU2381873111.SGD","LU0672654240.SGD","IE000MB6IJN5.SGD","LU1548497426.USD","LU0957791311.USD","LU0345768153.USD","LU1914381329.SGD","AMZZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633917715","title":"Ginkgo Bioworks reaffirms 2026 expected total cash burn of ($150M)-($125M)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633917715","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633917715?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:55","pubTimestamp":1778187319,"startTime":"0","endTime":"0","summary":"16:38 EDT Ginkgo Bioworks (DNA) reaffirms 2026 expected total cash burn of ($150M)-($125M) Published first on TheFly – the ultimate source for real...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ginkgo-bioworks-reaffirms-2026-expected-total-cash-burn-of-150m-125m-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ginkgo-bioworks-reaffirms-2026-expected-total-cash-burn-of-150m-125m-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DNA","BK4121","BK4109","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633174233","title":"Ginkgo Q1 FY26 net loss narrows 8.36% to $(76) million; revenue drops 49% to $19 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633174233","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633174233?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:33","pubTimestamp":1778185986,"startTime":"0","endTime":"0","summary":"Ginkgo Bioworks posted first-quarter revenue of USD 19 million, down 49%, while GAAP net loss from continuing operations narrowed to USD 76 million from USD 83 million a year earlier.Adjusted EBITDA loss improved to USD 42 million from USD 44 million.Cash, cash equivalents, and marketable securities totaled USD 373 million as of March 31.Biosecurity divestiture closed April 3, with former Biosecurity results now reported in discontinued operations.CEO Jason Kelly said Nebula is already “the world’s largest autonomous lab,” with Ginkgo targeting to double its size in 2026; full-year cash burn outlook reaffirmed at USD 150 million to USD 125 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ginkgo Bioworks Holdings Inc. published t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDL4TvHM1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4139","BK4109","DNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633179968","title":"Ginkgo Bioworks Holdings Q1 EPS $(1.39) Misses $(1.34) Estimate, Sales $19.474M Miss $41.520M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2633179968","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633179968?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:10","pubTimestamp":1778184619,"startTime":"0","endTime":"0","summary":"Ginkgo Bioworks Holdings Q1 EPS $(1.39) Misses $(1.34) Estimate, Sales $19.474M Miss $41.520M Estimate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/quote/DNA","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Ginkgo Bioworks Holdings Q1 EPS $(1.39) Misses $(1.34) Estimate, Sales $19.474M Miss $41.520M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","DNA","BK4109","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633795301","title":"BRIEF-Ginkgo Bioworks Q1 Net Income USD -82.587 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633795301","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633795301?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:05","pubTimestamp":1778184348,"startTime":"0","endTime":"0","summary":"BRIEF-Ginkgo Bioworks Q1 Net Income USD -82.587 Million\n\n\nMay 07 (Reuters) - Ginkgo Bioworks Q1 operating expenses USD 90.848 million.\n\nQ1 operating income USD -71.374 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nPLX318024:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","DNA","BK4109","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633711971","title":"Ginkgo Bioworks Holdings Inc - Reaffirms 2026 Total Cash Burn Guidance of $(150)-$(125) Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2633711971","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633711971?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:05","pubTimestamp":1778184303,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nPLX318024:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","DNA","BK4109","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633764691","title":"Press Release: Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab","url":"https://stock-news.laohu8.com/highlight/detail?id=2633764691","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633764691?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:05","pubTimestamp":1778184300,"startTime":"0","endTime":"0","summary":"Ginkgo provides an update on its first quarter financial results following the divestiture of its Biosecurity business. -- As previously announced, Ginkgo completed the divestiture of its. Biosecurity business on April 3, 2026 and is presenting the financial. results of operations for the former business within discontinued. for comparable periods have been retrospectively recast to conform to. this presentation and reflect Ginkgo as a single reporting segment.-- First quarter 2026 Revenue of $19 million compared to $38 million in the. comparable prior year period, a decrease of 49%. As previously reported,the first quarter of 2025 benefited from $7 million of non-cash revenue. deferred revenue release, first quarter 2026 Revenue of $19 million, down. from $31 million in the comparable prior year period, a decrease of 37%.million, compared to $ million in the comparable prior year period.-- We believe that autonomous labs will replace the bench.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4109","DNA","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633973814","title":"Ginkgo Bioworks Holdings Inc  expected to post a loss of $1.08 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2633973814","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633973814?lang=en_us&edition=fundamental","pubTime":"2026-05-06 06:51","pubTimestamp":1778021465,"startTime":"0","endTime":"0","summary":"Ginkgo Bioworks Holdings Inc  expected to post a loss of $1.08 a share - Earnings Preview Ginkgo Bioworks Holdings Inc DNA.N, DNA is expected to  show a fall in quarterly revenue when it reports  resu","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nL8N41I3TT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4109","DNA","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631634033","title":"Ginkgo Bioworks to host first-quarter results presentation and Q&A session","url":"https://stock-news.laohu8.com/highlight/detail?id=2631634033","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631634033?lang=en_us&edition=fundamental","pubTime":"2026-04-30 20:16","pubTimestamp":1777551413,"startTime":"0","endTime":"0","summary":"Ginkgo Bioworks scheduled first-quarter 2026 results presentation for May 7, 2026 at 4:30 p.m. ET.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL3qLBXW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DNA","BK4121","BK4139","BK4109"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631519820","title":"Candel Therapeutics Announces Commercialization Agreement with EVERSANA to Support Potential U.S. Launch of Aglatimagene Besadenovec in Localized Prostate Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2631519820","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631519820?lang=en_us&edition=fundamental","pubTime":"2026-04-29 20:05","pubTimestamp":1777464300,"startTime":"0","endTime":"0","summary":"EVERSANA, a purpose-built, partner-led commercial organization, positions Candel for potential U.S. commercial launch following planned BLA submission in Q4 2026 NEEDHAM, Mass., April  29, 2026 (GLOBE","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/29/3283732/0/en/Candel-Therapeutics-Announces-Commercialization-Agreement-with-EVERSANA-to-Support-Potential-U-S-Launch-of-Aglatimagene-Besadenovec-in-Localized-Prostate-Cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDEA","BK4139","BK4539","DNA","BK4135","CADL","BK4121","BK4109"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184571093","title":"Eli Lilly Emerges as Top Contender in Pharma's AI Arms Race with $2.25 Billion Profluent Partnership for DNA Editing Tech","url":"https://stock-news.laohu8.com/highlight/detail?id=1184571093","media":"Stock News","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184571093?lang=en_us&edition=fundamental","pubTime":"2026-04-28 21:32","pubTimestamp":1777383172,"startTime":"0","endTime":"0","summary":"Pharmaceutical leader Eli Lilly (LLY.US) has entered into a collaboration agreement with artificial intelligence (AI) startup Profluent, valued at up to $2.25 billion, to explore novel methods for...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"a7c05800a0bd0877086f62146defffa4","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2023250504.SGD","IE00BFSS8Q28.SGD","LU2552382058.USD","ELIL","LU2456880835.USD","LU2087625088.SGD","LU0234572021.USD","LU2746668974.SGD","IE00BJT1NW94.SGD","BK4109","IE00BKDWB100.SGD","AIPO","IE0001KFT4U8.USD","LU2361044949.HKD","LU0823416689.USD","LU1127390331.HKD","LU2111349929.HKD","LU2237443978.SGD","LU2168564149.EUR","LU2264538146.SGD","LU1868837300.USD","BK4533","BK4007","LU0823434740.USD","LU1061106388.HKD","LU2265009873.SGD","LU0353189763.USD","LU2552382132.HKD","LU0266013472.USD","LU0323591593.USD","LU1814569148.SGD","LU0943347566.SGD","LU1623119135.USD","SGXZ99366536.SGD","IE00BK4W5L77.USD","LU1023059063.AUD","LU1629891620.HKD","SG9999018865.SGD","LU0238689110.USD","LU0256863902.USD","LU2756315664.SGD","LU1064131342.USD","LU0417517546.SGD","LU0823434583.USD","BK4516","LU2063271972.USD","LU0882574055.USD","LU2168564065.EUR","IE00BFSS7M15.SGD","SGXZ81514606.USD","LLYX","01477","SG9999015952.SGD","IE00B2B36J28.USD","LU0820561909.HKD","LU0471298694.HKD","LU1989771016.USD","LU2237443549.SGD","LU0471298777.SGD","LU1917777945.USD","SG9999017495.SGD","IE0005OL40V9.USD","LU2211815571.USD","LU2237438978.USD","SG9999014914.USD","IE00BWXC8680.SGD","IE00BFTCPJ56.SGD","IE00B4JS1V06.HKD","SG9999015978.USD","LU2756315318.SGD","LU2360106947.USD","LLY","ARTY","IE00B4R5TH58.HKD","LU2471134879.HKD","IE00BN29S564.USD","LU0787776722.HKD","LU0820561818.USD","LU1983299246.USD","LU0708995401.HKD","AGIX","LU1232071149.USD","IE0009355771.USD","SG9999015986.USD","IE00BJLML261.HKD","LU2237443622.USD","LU1551013342.USD","SGXZ31699556.SGD","LU1366192091.USD","LU2417539215.USD","LU0079474960.USD","LU2602419157.SGD","BK4599","LU2271345857.HKD","SGXZ57979304.SGD","LU0889565916.HKD","LU0786609619.USD","LU1267930730.SGD","LU2361044865.SGD","LU1868836757.USD","SG9999001176.SGD","SG9999018857.SGD","LU2491049909.HKD","BK4588","LU1093756325.SGD","LU0320765059.SGD","LU1720051108.HKD","LU1548497426.USD","SG9999014880.SGD","LU0354030438.USD","LU0689472784.USD","BK4585","LU0820562030.AUD","LU2168564495.EUR","LU0203202063.USD","LU2471134523.USD","IE00B1XK9C88.USD","LU2324357040.USD","IE00BKPKM429.USD","LU0964807845.USD","LU2746668461.USD","LU2089984988.USD","LU0210536198.USD","LU2896262040.SGD","LU0354030511.USD","LU1868836914.USD","LU1974910355.USD","IE00B775H168.HKD","LU1712237335.SGD","LU2168564222.USD","LU0097036916.USD","LU2028103732.USD","IE00BK4W5M84.HKD","LU0256863811.USD","LU0058720904.USD","LU0640476718.USD","LU1720051017.SGD","LU2112291526.USD","LU2462157665.USD","LU0683600562.USD","IE0004445239.USD","LU2471134796.USD","LU0203201768.USD","LU2491050071.SGD","SG9999014906.USD","LU0320765992.SGD","IE0002141913.USD","LU2089284900.SGD","LU1035775433.USD","LU0006306889.USD","LU1551013425.SGD","LLII","BK4121","LU0114720955.EUR","LU0198837287.USD","LU0094547139.USD","IE00BJJMRX11.SGD","LU2023250330.USD","LU0158827948.USD","LU1804176565.USD","LU0061475181.USD","LU0882574139.USD","LU2023251221.USD","ELIS","BK1574","LU0096364046.USD","LU0353189680.USD","LU2750360997.AUD","LU2471134952.CNY","LU2750360641.GBP","LU0122379950.USD","LLYZ","LU1093756168.USD","LU2237443895.HKD","LU2361045086.USD","LU2108987350.USD","BK4581","LU1145028129.USD","LU0106261372.USD","LU0133085943.USD","LU1057294990.SGD","LU0289739699.SGD","LU1280957306.USD","LU0672654240.SGD","GB00BDT5M118.USD","LU1069344957.HKD","BK1191","LU0385154629.USD","LU2461242641.AUD","BK4139","LU0109391861.USD","LU2236285917.USD","SG9999013999.USD","LU0109394709.USD","LU2468319806.SGD","LU2491050154.USD","LU2106854487.HKD","LU2237443465.HKD","SGXZ51526630.SGD","LU0225283273.USD","LU2213496289.HKD","LU2357305700.SGD","IE0004445015.USD","IE00B7KXQ091.USD","IE00BJJMRY28.SGD","LU2552382215.SGD","CHAT","LU1868836591.USD","LU0158827781.USD","IE00B1BXHZ80.USD","LU2089283258.USD","LU0316494557.USD","LU2168563687.JPY","LU0466842654.USD","SG9999015945.SGD","LU1323610961.USD","SG9999014898.SGD","LU2237443382.USD","LU1291159041.SGD","BK4534","DNA","LU1988902786.USD","LU0456855351.SGD","LU1868837136.USD","LU0432979614.USD","IE00BJJMRZ35.SGD","SG9999001176.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630031087","title":"Cellectis Presents Epigenetic Editing Platform to Turn Genes Off Without Altering DNA at the ASGCT Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2630031087","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630031087?lang=en_us&edition=fundamental","pubTime":"2026-04-28 04:30","pubTimestamp":1777321800,"startTime":"0","endTime":"0","summary":"NEW YORK, April  27, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to de","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/27/3282051/0/en/Cellectis-Presents-Epigenetic-Editing-Platform-to-Turn-Genes-Off-Without-Altering-DNA-at-the-ASGCT-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2317271919.USD","LU2552382058.USD","LU2456880835.USD","LU0950375773.USD","BK4109","LU0174119429.USD","LU0061474960.USD","LU2461242641.AUD","LU0957791311.USD","LU0109391861.USD","LU1363072403.SGD","LU2506951958.HKD","LU2168564149.EUR","LU2417539215.USD","LU0823434740.USD","MA","LU0256863811.USD","LU1718418525.SGD","CLLS","LU2552382132.HKD","LU0390134368.USD","LU0210533765.USD","LU0053666078.USD","LU0077335932.USD","LU1983260115.SGD","LU2764263039.SGD","IE0004445015.USD","LU1868836591.USD","LU2168564065.EUR","LU1989772923.USD","IE00BJJMRX11.SGD","LU0316494557.USD","LU1815333072.USD","LU0820562030.AUD","LU2506951875.HKD","LU2168564495.EUR","LU0170899867.USD","LU0096362180.USD","LU1261432733.SGD","DNA","BK4566","LU0276348264.USD","LU0345770993.USD","LU2506952097.USD","LU1868837136.USD","LU1084165304.USD","IE00B1XK9C88.USD","IE0004086264.USD","LU2764262908.HKD","LU2756315318.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630355272","title":"How to Avoid Fistfights and DNA Leaks at a World Leaders Summit -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2630355272","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630355272?lang=en_us&edition=fundamental","pubTime":"2026-04-27 11:00","pubTimestamp":1777258800,"startTime":"0","endTime":"0","summary":"Xi Jinping had just finished a lunch of herbed-ricotta ravioli at a secluded estate outside San Francisco in 2023 when his security agents sprang into action.Their mission: ensuring no trace of the Chinese leader's DNA fell into foreign hands. The agents -- measuring about 6-foot-3, dressed in identical dark suits -- were observed grabbing Xi's utensils and plate and spraying them with an unidentified liquid.Welcome to the unseen theater of great-power diplomacy, where a meeting of the two most powerful leaders on earth can hinge on the slightest missed protocol, an unexpected miscue or even a bit of saliva left on a fork. It is a ritual that is at once deeply absurd and deadly serious. The length of a red carpet can say more about the state of the world than official statements.\"These visits are traumatic for those of us who have to organize them,\" said Rick Waters, a former State Department official who helped organize President Trump's visit to Beijing in 2017.It even matters who ri","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SMMF","BK4109","BK4211","BK4139","BK4121","DNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125970863","title":"Uncovering the Hidden Lineage of Large Models: Fine-Tuning and Distillation Secrets Revealed","url":"https://stock-news.laohu8.com/highlight/detail?id=1125970863","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125970863?lang=en_us&edition=fundamental","pubTime":"2026-04-25 19:21","pubTimestamp":1777116068,"startTime":"0","endTime":"0","summary":"The large language model ecosystem has evolved far beyond just a few dominant models. The number of models on Hugging Face continues to grow rapidly. Different families, various architectures, and...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","DNA","BK4139","BK4109"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628446067","title":"Nanobiotix Unveils Preclinical Data Showing Nanoprimer Boosts LNP-DNA Cancer Immunotherapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2628446067","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628446067?lang=en_us&edition=fundamental","pubTime":"2026-04-20 18:31","pubTimestamp":1776681064,"startTime":"0","endTime":"0","summary":"Nanobiotix ( ($NBTX) ) has issued an update. On April 20, 2026, Nanobiotix reported new preclinical data for its Nanoprimer platform, presented at ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nanobiotix-unveils-preclinical-data-showing-nanoprimer-boosts-lnp-dna-cancer-immunotherapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nanobiotix-unveils-preclinical-data-showing-nanoprimer-boosts-lnp-dna-cancer-immunotherapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4109","BK4121","BK4139","DNA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ginkgobioworks.com","stockEarnings":[{"period":"1week","weight":-0.1366},{"period":"1month","weight":-0.0103},{"period":"3month","weight":-0.1701},{"period":"6month","weight":-0.0399},{"period":"1year","weight":0.0052},{"period":"ytd","weight":-0.0722}],"compareEarnings":[{"period":"1week","weight":0.0021},{"period":"1month","weight":0.056},{"period":"3month","weight":0.0842},{"period":"6month","weight":0.1001},{"period":"1year","weight":0.2519},{"period":"ytd","weight":0.084}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.00587},{"month":2,"riseRate":0.2,"avgChangeRate":-0.173635},{"month":3,"riseRate":0,"avgChangeRate":-0.167326},{"month":4,"riseRate":0.4,"avgChangeRate":0.015633},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.038589},{"month":6,"riseRate":0.6,"avgChangeRate":0.042062},{"month":7,"riseRate":0.8,"avgChangeRate":0.169362},{"month":8,"riseRate":0.2,"avgChangeRate":-0.142535},{"month":9,"riseRate":0.8,"avgChangeRate":0.092966},{"month":10,"riseRate":0.2,"avgChangeRate":-0.069954},{"month":11,"riseRate":0.2,"avgChangeRate":-0.122886},{"month":12,"riseRate":0.4,"avgChangeRate":-0.023276}],"exchange":"NYSE","name":"Ginkgo Bioworks Holdings Inc.","nameEN":"Ginkgo Bioworks Holdings Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ginkgo Bioworks Holdings Inc.(DNA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Ginkgo Bioworks Holdings Inc.(DNA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Ginkgo Bioworks Holdings Inc.,DNA,Ginkgo Bioworks Holdings Inc.股票,Ginkgo Bioworks Holdings Inc.股票老虎,Ginkgo Bioworks Holdings Inc.股票老虎国际,Ginkgo Bioworks Holdings Inc.行情,Ginkgo Bioworks Holdings Inc.股票行情,Ginkgo Bioworks Holdings Inc.股价,Ginkgo Bioworks Holdings Inc.股市,Ginkgo Bioworks Holdings Inc.股票价格,Ginkgo Bioworks Holdings Inc.股票交易,Ginkgo Bioworks Holdings Inc.股票购买,Ginkgo Bioworks Holdings Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ginkgo Bioworks Holdings Inc.(DNA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Ginkgo Bioworks Holdings Inc.(DNA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction